ACRV – acrivon therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer [Yahoo! Finance]
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Acrivon Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
Acrivon Therapeutics (NASDAQ:ACRV) was upgraded by analysts at Wall Stre
Form 8-K Acrivon Therapeutics, For: Feb 27
Form 4 Acrivon Therapeutics, For: Feb 21 Filed by: Blume-Jensen Peter
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Peterson Katharine
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Miller Mary
Form 4 Acrivon Therapeutics, For: Feb 14 Filed by: Gamelin Erick
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.